Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Baxter

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Basic Research in Cardiology|June 1, 1997
Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardiumG F Baxter, F M Goma, D M Yellon
British Journal of Pharmacology|May 12, 2000
Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injuryM M Mocanu, G F Baxter, D M Yellon
Circulation|December 1, 1996
Oxidative stress and the second window of protection after preconditioningG F Baxter, R J Heads, D M Yellon
British Journal of Pharmacology|May 1, 1995
Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardiumG F Baxter, F M Goma, D M Yellon
Circulation|August 15, 1995
Prodromal angina limits infarct size: a role for ischemic preconditioningM S Marber, G F Baxter, D M Yellon
Lancet (London, England)|November 23, 1996
Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studiesG F Baxter, M S Sumeray, J M Walker
Journal of Molecular and Cellular Cardiology|July 1, 1997
Attenuation of myocardial ischaemic injury 24 h after diacylglycerol treatment in vivoG F Baxter, M M Mocanu, D M Yellon
Pharmacological Research|March 1, 1995
The pathophysiology of ischaemic preconditioningD P Jenkins, G F Baxter, D M Yellon
Lancet (London, England)|April 27, 1996
Angina reassessed: pain or protector?D M Yellon, G F Baxter, M S Marber
Cardiovascular Research|July 1, 1994
Ischaemic preconditioning protects hypertrophied myocardiumM E Speechly-Dick, G F Baxter, D M Yellon
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Basic Research in Cardiology|June 1, 1997
Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardiumG F Baxter, F M Goma, D M Yellon
British Journal of Pharmacology|May 12, 2000
Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injuryM M Mocanu, G F Baxter, D M Yellon
Circulation|December 1, 1996
Oxidative stress and the second window of protection after preconditioningG F Baxter, R J Heads, D M Yellon
British Journal of Pharmacology|May 1, 1995
Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardiumG F Baxter, F M Goma, D M Yellon
Circulation|August 15, 1995
Prodromal angina limits infarct size: a role for ischemic preconditioningM S Marber, G F Baxter, D M Yellon
Lancet (London, England)|November 23, 1996
Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studiesG F Baxter, M S Sumeray, J M Walker
Journal of Molecular and Cellular Cardiology|July 1, 1997
Attenuation of myocardial ischaemic injury 24 h after diacylglycerol treatment in vivoG F Baxter, M M Mocanu, D M Yellon
Pharmacological Research|March 1, 1995
The pathophysiology of ischaemic preconditioningD P Jenkins, G F Baxter, D M Yellon
Lancet (London, England)|April 27, 1996
Angina reassessed: pain or protector?D M Yellon, G F Baxter, M S Marber
Cardiovascular Research|July 1, 1994
Ischaemic preconditioning protects hypertrophied myocardiumM E Speechly-Dick, G F Baxter, D M Yellon
Pageof 7